Vectus Biosystems Ltd (VBS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.572x

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has a cash flow conversion efficiency ratio of 2.572x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-659.98K ≈ $-466.98K USD) by net assets (AU$-256.62K ≈ $-181.58K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vectus Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Vectus Biosystems Ltd for a breakdown of total debt and financial obligations.

Vectus Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vectus Biosystems Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Winshear Gold Corp V:WINS	-0.494x
Xpon Technologies Group Ltd AU:XPN	1.398x
Comperia.pl S.A. WAR:CPL	0.078x
RWS Holdings PLC LSE:RWS	0.039x
Xamble Group Ltd AU:XGL	-0.126x
Rare Earth Magnesium Technology Group Holdings Limited STU:GPS	0.016x
Spenda Ltd AU:SPX	-0.443x
FRNT Financial Inc V:FRNT	-0.249x

Annual Cash Flow Conversion Efficiency for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Vectus Biosystems Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Vectus Biosystems Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-256.62K ≈ $-181.58K	AU$-830.09K ≈ $-587.34K	3.235x	+336.52%
2024-06-30	AU$1.49 Million ≈ $1.05 Million	AU$-2.03 Million ≈ $-1.44 Million	-1.368x	-104.82%
2023-06-30	AU$3.52 Million ≈ $2.49 Million	AU$-2.35 Million ≈ $-1.66 Million	-0.668x	-166.48%
2022-06-30	AU$-4.42 Million ≈ $-3.13 Million	AU$-4.44 Million ≈ $-3.14 Million	1.004x	-10.54%
2021-06-30	AU$-2.90 Million ≈ $-2.05 Million	AU$-3.26 Million ≈ $-2.30 Million	1.123x	+151.03%
2020-06-30	AU$-6.71 Million ≈ $-4.75 Million	AU$-3.00 Million ≈ $-2.12 Million	0.447x	+60.32%
2019-06-30	AU$-3.73 Million ≈ $-2.64 Million	AU$-1.04 Million ≈ $-736.30K	0.279x	-54.62%
2018-06-30	AU$-2.26 Million ≈ $-1.60 Million	AU$-1.39 Million ≈ $-981.46K	0.615x	+101.84%
2017-06-30	AU$116.56K ≈ $82.48K	AU$-3.89 Million ≈ $-2.75 Million	-33.399x	-4696.01%
2016-06-30	AU$3.75 Million ≈ $2.65 Million	AU$-2.61 Million ≈ $-1.85 Million	-0.696x	-376.09%
2015-06-30	AU$11.22 Million ≈ $7.94 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.146x	+99.37%
2014-06-30	AU$55.53K ≈ $39.29K	AU$-1.29 Million ≈ $-915.18K	-23.292x	-1926.15%
2013-06-30	AU$976.04K ≈ $690.61K	AU$-1.12 Million ≈ $-793.92K	-1.150x	-141.21%
2012-06-30	AU$-504.57K ≈ $-357.02K	AU$-1.41 Million ≈ $-995.86K	2.789x	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.16 Million

AU$5.88 Million AUD

Market Cap Rank

#28694 Global

#1627 in Australia

Share Price

AU$0.11

Change (1 day)

-8.33%

52-Week Range

AU$0.04 - AU$0.44

All Time High

AU$2.00